Select region
Submit

Subscribe to our news feed

Subscribe

A question?

11/11/2024
Getinge Announces Official Cybersecurity Clearance From the US Defense Health Agency for Servo Ventilators

As of earlier this year, under the clearance and Authority to Operate (ATO) certification from the US Defense Health Agency (DHA), Getinge’s Servo ventilators can now be purchased by the US Department of Defense (DOD) and operate within their strict networking environments.

11/7/2024
Alexandra Holland appointed as EVP Communications at Getinge

Getinge appoints Alexandra Holland as the new Executive Vice President of Communications effective November 11, 2024. Alexandra will become a member of the Getinge Executive Team and lead the development, advancement, and execution of the company’s communications and public affairs strategy.

11/6/2024
Contributing to a legacy of life-saving technology

Meet Carl Famulare, a technical associate and long-time member of the Getinge family who recently participated in Getinge’s 2024 company video highlighting the purpose to make life-saving technology accessible for more people.

10/28/2024
Paragonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion system

Paragonix Technologies, a leading organ preservation company recently acquired by Getinge, receives FDA clearance for the innovative transportable perfusion device KidneyVault, to optimize standard of care in kidney preservation.

10/18/2024
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

“The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased by 3.5%, of which the organic increase was 0.2%, while the operating margin weakened compared with last year.

10/4/2024
Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call

Getinge will issue its Q3 Report 2024 on October 18, 2024, at 08:00 a.m. CEST, followed by a conference call at 10.00-11.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Press Contacts

Caroline Örmgård

Head of Public & Media Relations
Phone: +46 10 335 0041

Newsroom2

Contact us online

Click below to fill in the appropriate form. We will be in touch shortly.

Are you looking for

Getinge Hybrid OR

Image Gallery

Diverse picture format made available for press article purpose 

Man and woman looking a something together

About us

All you need to know about Getinge a one glance

Cardiosave

Urgent Medical Device Correction

Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)

Newsroom

Don't miss anything

Click on the icons and follow us!